Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Rochester today announced the release of two seminal publications about digital health technologies for Parkinson’s.
Amneal’s IPX203 is an oral extended-release (ER) capsule formulation of levodopa that is designed to sustain levodopa plasma concentrations and control motor fluctuations in PD patients
Smartwatches are not just handy and fancy gadgets, but they may also have particular health benefits, as they can help diagnose Parkinson’s disease up…
The study was conducted from 2013 to 2016 and it compared the data from people who already had Parkinson’s disease with those who were diagnosed up to seven years after the smartwatch data was collected.
London: Smartwatches could identify Parkinson’s disease up to seven years before hallmark symptoms appear and a clinical diagnosis can be made, according